Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 2,051–2,100 of 2,289 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00031564	Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2	completed	Phase 2	49	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 27, 2012	clinicaltrials
NCT00003939	Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	completed	Phase 2	132	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	0	Sep 24, 2012